Tech Company Financing Transactions
TrialClinIQ Funding Round
TrialClinIQ, operating out of Katy, scored $150 million in investment from Caduceus Capital Partners and private investors.
Transaction Overview
Company Name
Announced On
4/29/2026
Transaction Type
Venture Equity
Amount
$150,000,000
Round
Seed
Investors
Caduceus Capital Partners (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
HRTech
Mailing Address
20180 Park Row Drive 5126
Katy, TX 77449
USA
Katy, TX 77449
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
TrialClinIQ is the bridge between community health centers and clinical research. We partner with CHCs to integrate with their EHR systems, leveraging AI to identify trial-eligible patients who can be connected--with consent--to local clinical trial sites operated by our CRO and pharma sponsor partners.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jontel Pierce
Chief Technical Officer
Chandler Stevenson
VP - General Counsel
Janette Obi
Browse more venture capital transactions:
Prev: 4/29/2026: Noreja venture capital transaction
Next: 4/29/2026: Tacalyx venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs